Stock Futures Dip as Investors Await Trade Talk Updates, Inflation Data Looms
U.S. stock futures edged down slightly on Tuesday evening as investors looked ahead to updates from the U.S.-China trade policy talks. They are also bracing for the release of May's Consumer Price Index (CPI) report, due today. Futures on the Nasdaq 100 (NDX), the Dow Jones Industrial Average (DJIA), and the S&P 500 (SPX) were up 0.08%, 0.02%, and 0.03%, respectively, at 8:23 p.m. EST, June 10.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
U.S. and Chinese officials held a second day of trade talks in London on Tuesday. The discussions remain a major focus for investors, with markets still on edge about any surprises related to trade policy.
During Tuesday's regular session, the S&P 500 rose nearly 0.6%, marking its third straight day of gains. The Dow Jones climbed 0.3%, while the Nasdaq Composite (NDAQ) closed higher by 0.66%.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
32 minutes ago
- Bloomberg
S&P 500 Slumps After Trump Revives Unilateral Tariff Threats
The S&P 500 Index extended losses for a second-straight session Thursday after Wall Street's rally stalled, with traders looking past another cooling inflation print and reacting little to the latest round of US-China trade talks. The equities benchmark fell 0.3% as of 9:37 a.m. in New York, coming off its first loss in four sessions on Wednesday as several Big Tech stocks continued to lead the way lower. The Nasdaq 100 Index slipped 0.2%, as a basket tracking the Magnificent Seven stocks like Nvidia Corp. and Inc. fell 0.4%. Alphabet Inc., Meta Platforms Inc. and Tesla Inc. all declined. Oracle Corp. jumped 9.1% — the best S&P 500 performer — after the software company's AI infrastructure demand remained strong.
Yahoo
40 minutes ago
- Yahoo
US stock futures fall after Trump raises tariff tensions
U.S. stock futures are lower after President Donald Trump raises tariff tensions again by promising unilateral tariff rates within two weeks. He said he will send letters to trading partners in the next couple of weeks setting unilateral tariff rates, ahead of a July 9 deadline to reimpose higher duties on dozens of economies. Trump's new tariff threat contrasts with the more positive tone officials tried to strike after reaching a trade framework with China in London and earlier remarks from Treasury Secretary Scott Bessent. Bessent said at a hearing before the House Ways and Means Committee that the Trump administration though was open to extending the current 90-day tariff pause beyond July 9 for the U.S.′ top trading partners, as long as they show 'good faith' in ongoing trade negotiations. Futures linked to the blue-chip Dow fell -0.60%, while broad S&P 500 futures dropped -0.41% and tech-heavy Nasdaq futures slipped -0.35.%. Another set of inflation data are due before the opening bell. Producer prices, or the the prices businesses pay for their goods and services, are expected to rise 2.3% on an annual basis in May, according to Bank of America economists. Without the volatile food and energy sectors, producer prices are seen up 2.7%, they said. Some economists expect some tariff-related inflation to appear as inflation first can be seen by businesses, before price increases are passed on to consumers. Oracle's results in the final three months of its fiscal year topped Street views. The company also said cloud infrastructure revenue will rise by more than 70% in fiscal 2026, up from a 50% growth rate in the prior fiscal year. Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday morning. This article originally appeared on USA TODAY: US stock futures fall after Trump raises tariff tensions Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
40 minutes ago
- Yahoo
Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?
If you have been looking for Sector - Health funds, a place to start could be Fidelity Select Portfolio Medical Technology and Devices (FSMEX). FSMEX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance. Zacks categorizes FSMEX as Sector - Health, a segment packed with options. Sector - Health mutual funds offer investors a focus on the healthcare industry, one of the largest sectors in the American economy. These funds can include everything from pharmaceutical companies to medical device manufacturers and for-profit hospitals. Fidelity is responsible for FSMEX, and the company is based out of Boston, MA. Fidelity Select Portfolio Medical Technology and Devices made its debut in April of 1998, and since then, FSMEX has accumulated about $4.48 billion in assets, per the most up-to-date date available. The fund is currently managed by Edward Yoon who has been in charge of the fund since May of 2007. Investors naturally seek funds with strong performance. This fund has delivered a 5-year annualized total return of 5.12%, and it sits in the middle third among its category peers. If you're interested in shorter time frames, do not dismiss looking at the fund's 3 -year annualized total return of 3.37%, which places it in the bottom third during this time-frame. It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, FSMEX's standard deviation comes in at 18.22%, compared to the category average of 15.64%. Over the past 5 years, the standard deviation of the fund is 19.24% compared to the category average of 16.64%. This makes the fund more volatile than its peers over the past half-decade. Investors should note that the fund has a 5-year beta of 0.92, which means it is hypothetically less volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. With a negative alpha of -7.95, managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns. Costs are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, FSMEX is a no load fund. It has an expense ratio of 0.63% compared to the category average of 1.11%. Looking at the fund from a cost perspective, FSMEX is actually cheaper than its peers. While the minimum initial investment for the product is $0, investors should also note that there is no minimum for each subsequent investment. Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included. Overall, Fidelity Select Portfolio Medical Technology and Devices ( FSMEX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively similar performance, average downside risk, and lower fees, Fidelity Select Portfolio Medical Technology and Devices ( FSMEX ) looks like a great potential choice for investors right now. Your research on the Sector - Health segment doesn't have to stop here. You can check out all the great mutual fund tools we have to offer by going to to see the additional features we offer as well for additional information. For analysis of the rest of your portfolio, make sure to visit for our full suite of tools which will help you investigate all of your stocks and funds in one place. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (FSMEX): Fund Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
